Passive immunization against COVID-19 by anti-SARS-CoV-2 spike IgG in commercially available immunoglobulin preparations in severe antibody deficiency

Detalles Bibliográficos
Autores principales: Hirsiger, Julia R., Weigang, Sebastian, Walz, Antje-Christine, Fuchs, Jonas, Daly, Mary-Louise, Eggimann, Stefan, Hausmann, Oliver, Schwemmle, Martin, Kochs, Georg, Panning, Marcus, Warnatz, Klaus, Recher, Mike, Berger, Christoph T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Academy of Allergy, Asthma & Immunology 2022
Materias:
Clinical Communications
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9239915/
https://www.ncbi.nlm.nih.gov/pubmed/35779780
http://dx.doi.org/10.1016/j.jaip.2022.06.020

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9239915/
https://www.ncbi.nlm.nih.gov/pubmed/35779780
http://dx.doi.org/10.1016/j.jaip.2022.06.020

Ejemplares similares